Amanote Research

Amanote Research

    RegisterSign In

Cannabidiol in Patients With Treatment-Resistant Epilepsy

The Lancet Neurology - United Kingdom
doi 10.1016/s1474-4422(16)00118-6
Full Text
Open PDF
Abstract

Available in full text

Categories
Neurology
Date

May 1, 2016

Authors
Prisca R BauerJosemir W Sander
Publisher

Elsevier BV


Related search

Cannabidiol as a Treatment for Epilepsy

Journal of Neurology
Neurology
2017English

Cannabidiol for Treatment of Childhood Epilepsy–A Cross-Sectional Survey

Frontiers in Neurology
Neurology
2018English

Long-Term Seizure Outcomes in Patients With Drug Resistant Epilepsy

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2018English

Perampanel in the Treatment of Patients With Epilepsy

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2017English

Could Cannabidiol Be a Treatment Option for Intractable Childhood and Adolescent Epilepsy?

Journal of Epilepsy Research
2017English

Carotid Sinus Syndrome Masquerading as Treatment Resistant Epilepsy

Postgraduate Medical Journal
Medicine
2000English

Cannabidiol Drug Approved for Use in Two Forms of Epilepsy

Pharmacy Today
2018English

Maintenance Electroconvulsive Therapy in a Patient With Treatment-Resistant Paranoid Schizophrenia and Comorbid Epilepsy

Case Reports in Psychiatry
PsychiatryMental Health
2012English

Outcomes of Surgical Treatment of Patients With Pharmacoresistant Epilepsy

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy